即將上市(暗盤交易時(shí)段:今日16:15-18:30)
| 公司名稱▼
/
代號(hào)▼ | 行業(yè) | 招股價(jià) | 每手股數(shù) | 入場費(fèi) | 招股截止日 | 暗盤日期▼ | 上市日期▲ |
|
公司名稱/代號(hào) | 現(xiàn)價(jià)2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帳率 (倍)▼ | 派息比率 (%)▼ | 股東權(quán)益 回報(bào)率(%)▼ | 經(jīng)營 利潤率(%)▼ | 總債項(xiàng)/ 股東權(quán)益(%)▼ | 選擇比較 |
盛禾生物-B 02898.HK | 5.500 | 0.000% | +4.17% | 8.62億 | N/A | 1.58 | N/A | -1,562.00% | N/A | 805.00% | |
信達(dá)生物 01801.HK | 77.200 | +5.537% | +36.52% | 1,275.02億 | N/A | 9.07 | N/A | -72.00% | 32.00% | 2,158.00% | |
中國生物制藥 01177.HK | 4.660 | +2.418% | +14.78% | 874.25億 | 22.90 | 2.58 | 34.398% | 1,095.00% | 2,562.00% | 3,038.00% | |
康方生物 09926.HK | 85.450 | +3.891% | +4.98% | 766.99億 | N/A | 10.58 | N/A | -755.00% | -1,715.00% | 5,800.00% | |
科倫博泰生物-B 06990.HK | 344.600 | +1.832% | +9.19% | 540.51億 | N/A | 22.26 | N/A | -806.00% | -718.00% | 383.00% | |
三生制藥 01530.HK | 21.650 | +7.178% | +14.79% | 519.47億 | 23.60 | 3.16 | 27.254% | 1,354.00% | 2,811.00% | 2,303.00% | |
藥明合聯(lián) 02268.HK | 41.950 | +0.600% | +17.18% | 504.60億 | 44.20 | 7.13 | N/A | 1,611.00% | 3,018.00% | 748.00% | |
諾誠健華 09969.HK | 13.320 | +13.073% | +28.82% | 234.55億 | N/A | 3.28 | N/A | -655.00% | -4,097.00% | 1,891.00% | |
和黃醫(yī)藥 00013.HK | 25.000 | +3.734% | +21.65% | 217.90億 | 73.01 | 3.69 | N/A | 496.00% | 28.00% | 1,182.00% | |
映恩生物-B 09606.HK | 237.800 | +10.914% | +19.68% | 209.35億 | N/A | N/A | N/A | -5,195.00% | -5,225.00% | N/A | |
綠葉制藥 02186.HK | 3.130 | +6.463% | +46.26% | 117.74億 | 23.46 | 0.78 | N/A | 333.00% | 2,313.00% | 7,292.00% | |
同源康醫(yī)藥-B 02410.HK | 24.000 | +1.266% | +6.67% | 87.89億 | N/A | 17.84 | N/A | -8,249.00% | -35,057,103.00% | 3,770.00% | |
MIRXES-B 02629.HK | 29.300 | -1.014% | +0.51% | 80.97億 | N/A | N/A | N/A | -4,427.00% | -39,819.00% | N/A | |
復(fù)宏漢霖 02696.HK | 48.550 | +6.469% | +15.32% | 79.34億 | 30.24 | 8.23 | N/A | 2,723.00% | 1,692.00% | 12,106.00% | |
康寧杰瑞制藥-B 09966.HK | 8.100 | +1.631% | -6.36% | 77.94億 | 44.07 | 4.00 | N/A | 908.00% | 2,754.00% | 1,015.00% | |
博安生物 06955.HK | 11.640 | +4.865% | +20.25% | 62.38億 | 80.17 | 3.57 | N/A | 445.00% | 1,457.00% | 4,170.00% | |
宜明昂科-B 01541.HK | 14.280 | +1.277% | +44.24% | 56.59億 | N/A | 8.06 | N/A | -4,652.00% | -42,231.00% | 2,009.00% | |
維升藥業(yè)-B 02561.HK | 47.300 | +3.388% | +2.94% | 53.89億 | N/A | N/A | N/A | -7,553.00% | N/A | 98.00% | |
君實(shí)生物 01877.HK | 22.350 | +4.684% | +40.92% | 49.01億 | N/A | 3.52 | N/A | -2,181.00% | -6,532.00% | 4,986.00% | |
綠竹生物-B 02480.HK | 24.050 | +1.907% | +18.77% | 47.91億 | N/A | 5.33 | N/A | -1,971.00% | N/A | 791.00% | |
派格生物醫(yī)藥-B 02565.HK | 9.600 | -0.208% | N/A | 37.05億 | N/A | N/A | N/A | -14,693.00% | N/A | 3,629.00% | |
|